arrow_back Back to App

Formula Act of 2022: Boosting Infant Formula Supply and Access.

This act aims to increase the availability of infant formula in the United States. It temporarily allows duty-free and quota-free importation of formula and provides flexibility in regulations to expedite market entry. Additionally, it modifies the WIC program to ensure beneficiaries have easier access to formula during shortages.
Key points
Temporary removal of duties and quantitative limits on infant formula imports for 180 days to boost supply.
Facilitating formula imports from countries with similar safety standards, including European Union members.
Issuing guidance for manufacturers to quickly increase production of safe and nutritionally adequate infant formula.
Allowing WIC beneficiaries to purchase imported formula and providing program flexibility during supply disruptions.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_4262
Sponsor: Sen. Lee, Mike [R-UT]
Process start date: 2022-05-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Formula Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_4262.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-05-19.

What are the main provisions?

Key points include:

  • Temporary removal of duties and quantitative limits on infant formula imports for 180 days to boost supply.
  • Facilitating formula imports from countries with similar safety standards, including European Union members.
  • Issuing guidance for manufacturers to quickly increase production of safe and nutritionally adequate infant formula.
  • Allowing WIC beneficiaries to purchase imported formula and providing program flexibility during supply disruptions.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Lee, Mike [R-UT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Family Benefits